Matrix metalloproteinase-1, soluble Fas ligand, and soluble Fas antigen levels in patients with multiple organ dysfunction syndrome

Matrix metalloproteinase-1, soluble Fas ligand, and soluble Fas antigen levels in patients with multiple organ dysfunction syndrome

Bibliographic Details
Main Authors:	Endo, S, Kasai, T, Takakuwa, T, Nakae, H, Yamada, Y, Inada, K, Taniguchi, S
Format:	Online
Language:	English
Published:	BioMed Central 1998
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3301273/

Similar Items

Matrix metalloproteinases and soluble Fas/FasL system as novel regulators of apoptosis in children and young adults on chronic dialysis
by: Musiał, Kinga, et al.
Published: (2011)

Soluble Fas and the −670 Polymorphism of Fas in Lupus Nephritis
by: Bollain-y-Goytia, Juan José, et al.
Published: (2014)

Soluble Fas ligand inhibits angiogenesis in rheumatoid arthritis
by: Kim, Wan-Uk, et al.
Published: (2007)

Membrane Fas Ligand Kills Human Peripheral Blood T Lymphocytes, and Soluble Fas Ligand Blocks the Killing
by: Suda, Takashi, et al.
Published: (1997)

Plasma nuclear matrix protein (NMP) levels in patients with multiple organ failure
by: Endo, S, et al.
Published: (1997)

Enhancing Production and Cytotoxic Activity of Polymeric Soluble FasL-Based Chimeric Proteins by Concomitant Expression of Soluble FasL
by: Morello, Aurore, et al.
Published: (2013)

Cumulus cells accelerate oocyte aging by releasing soluble Fas Ligand in mice
by: Zhu, Jiang, et al.
Published: (2015)

Metalloproteinase-mediated release of human Fas ligand
Published: (1995)

Expression of Fas antigen and Fas ligand in bronchoalveolar lavage from silicosis patients.
by: Hamzaoui, Agnès, et al.
Published: (2003)

Circulating soluble Fas levels and risk of ovarian cancer
by: Akhmedkhanov, Arslan, et al.
Published: (2003)

Fas–Fas Ligand: Checkpoint of T Cell Functions in Multiple Sclerosis
by: Volpe, Elisabetta, et al.
Published: (2016)

Plasma concentrations of soluble Fas receptors (Fas) and Fas ligands (FasL) in relation to CD4+ cell counts in HIV-1 positive and negative patients in Yaounde, Cameroon
by: Ikomey, George M, et al.
Published: (2012)

Understanding the role of Fas-Fas ligand system in bone
by: Marusic, Ana, et al.
Published: (2012)

Differential expressions of Fas and Fas ligand in human placenta.
by: Roh, Cheong-Rae, et al.
Published: (2002)

Adhesion molecule, soluble adhesion molecule, and cytokine levels in patients with severe burns
by: Endo, S, et al.
Published: (1998)

Fas and activation-induced Fas ligand mediate apoptosis of T cell hybridomas: inhibition of Fas ligand expression by retinoic acid and glucocorticoids
Published: (1995)

Dynamic Changes of Soluble Fas and IL-2/IL-10 in serum and Fas Expression in Lung in the Rats of Acute Necrotizing Pancreatitis
by: Zhang, Jian Xin, et al.
Published: (2008)

Spontaneous Development of Plasmacytoid Tumors in Mice with Defective Fas–Fas Ligand Interactions
by: Davidson, Wendy F., et al.
Published: (1998)

Fas and Fas Ligand Interactions Suppress Melanoma Lung Metastasis
by: Owen-Schaub, Laurie B., et al.
Published: (1998)

Differential Induction of Apoptosis by Fas–Fas Ligand Interactions in Human Monocytes and Macrophages
by: Kiener, Peter A., et al.
Published: (1997)

Selective activation of Fas/Fas ligand-mediated cytotoxicity by a self peptide
Published: (1996)

Dexamethasone effect on sFas/sFas ligand following cardiopulmonary bypass
by: Joashi, U, et al.
Published: (2001)

Prognostic value of the Fas/Fas ligand system in breast cancer
by: Bębenek, Marek, et al.
Published: (2013)

Association of FAS and FAS Ligand Genes Polymorphism and Risk of Systemic Lupus Erythematosus
by: Moudi, Bita, et al.
Published: (2013)

The Role of Fas/Fas Ligand System in the Pathogenesis of Liver Cirrhosis and Hepatocellular Carcinoma
by: Hammam, Olfat, et al.
Published: (2012)

Expression Profile of Fas-Fas Ligand in Spiral Ganglion Cells During Apoptosis
by: Gu, Tae Woo, et al.
Published: (2014)

FAS and FAS-Ligand Promoter Polymorphisms in Hepatitis B Virus Infection
by: Mohammadi, Asadollah, et al.
Published: (2015)

Disruption of Fas-Fas Ligand Signaling, Apoptosis, and Innate Immunity by Bacterial Pathogens
by: Caulfield, Adam J., et al.
Published: (2014)

Levels of soluble Fas/APO-1 in patients with Behçet's disease.
by: Hamzaoui, K, et al.
Published: (1998)

A naturally occurring soluble isoform of murine Fas generated by alternative splicing
Published: (1995)

Serum soluble-Fas, inflammation and anemia in acute renal failure and critical illness
by: Góes, MA, et al.
Published: (2011)

Regulation of fibroblast Fas expression by soluble and mechanical pro-fibrotic stimuli
by: Amos E. Dodi, et al.
Published: (2018-05-01)

The Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand
Published: (1996)

FAS Ligand Triggers Pulmonary Silicosis
by: Borges, Valéria M., et al.
Published: (2001)

NaCS-PDMDAAC immobilized cultivation of recombinant Dictyostelium discoideum for soluble human Fas ligand production
by: Zheng, C., et al.
Published: (2015)

Opposing Effects of Transmembrane and Soluble FAS Ligand Expression on Inflammation and Tumor Cell Survival
by: Hohlbaum, Andreas M., et al.
Published: (2000)

Opposing Roles for Membrane Bound and Soluble Fas Ligand in Glaucoma-Associated Retinal Ganglion Cell Death
by: Gregory, Meredith S., et al.
Published: (2011)

Functional Characterization of a Chimeric Soluble Fas Ligand Polymer with In Vivo Anti-Tumor Activity
by: Daburon, Sophie, et al.
Published: (2013)

Level of a narcotic factor of the tumour-α and soluble form FAS-ligand in plasma of blood of patients with papiloma virus infection
by: S M Mizieva, et al.
Published: (2009-12-01)

Mesenchymal stem cells inhibit multiple myeloma cells via the Fas/Fas ligand pathway
by: Atsuta, Ikiru, et al.
Published: (2013)